mdtravel launches dérive

mdtravel launches dérive, an online booking solution to simplify corporate travel management for the pharmaceutical and healthcare industries

Berkshire, January 25, 2018/ - - There are several corporate booking tools on the market, but none like dérive: the online corporate travel management solution that meets the specific needs of pharmaceutical and biotech executives, physicians and patients.

Launched this week by mdtravel (part of mdgroup), a specialist travel management company for the pharmaceutical and healthcare industries, dérive is a total business travel management solution, offering healthcare travellers greater convenience, while reducing costs and compliance complications for companies.

dérive centralises and streamlines the booking process, offering travellers 24/7 access to flights, trains, transfers and accommodation at discounted rates. Fees are based on a per booking basis, so clients only pay for the services they require and that comply with company travel policies.

dérive: enhancing Pharma’s corporate travel experience

Commenting on the launch, Eloise Moffett, Business Development Manager, mdtravel states:

“dérive delivers a better corporate travel experience for healthcare and pharma executives and their employers. The name dérive reflects the traveller-centric nature of the booking solution and our traffic light system ensures compliance with corporate travel policies.”

Tarquin Scadding-Hunt, mdgroup CEO says: “Our goal is to simplify our clients’ travel management at every stage. With dérive, we’re helping clients manage travel-related bookings and costs, while providing peace of mind with live employee tracking and
24-hour support services".

Email to find out what dérive can do for your business.

About mdgroup

mdgroup is the parent company of mdevents, patientprimary and mdtravel. We’re committed to getting life-saving products to patients faster, by providing services and software solutions that help pharmaceutical and biotech companies engage employees, physicians and patients in clinical trials and drug development.